Targeting acquired resistance to oncogenic KRAS inhibition in Pancreatic cancer models using quantitative chemoproteomics
Targeting acquired resistance to oncogenic KRAS inhibition in Pancreatic cancer models using quantitative chemoproteomics
使用定量化学蛋白质组学靶向胰腺癌模型中对致癌 KRAS 抑制的获得性抗性
批准号：
376788
负责人：
Chandhoke Amrita Singh
金额：
$10.93万
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-11-01 至 2020-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pancreatic cancer, being the seventh leading cause of cancer-related deaths globally, has dismal five-year survival rates of 8 percent. With limited opportunities of early detection of pancreatic cancer and the current treatment options including chemoth
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
